Has Krishna Surapaneni, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,393 in general payments to Krishna Surapaneni, MD across 170 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Krishna Surapaneni, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Krishna Surapaneni, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Krishna Surapaneni, MD

Ophthalmology · Houston, TXNPI 1215321427

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $10,993 of the $12,393 with a category attached, or 88.7%. 21 manufacturers reported payments, led by Alcon at 28.6% of the total.

$12,393in general payments, 2019–2025

Across 170 payments — averaging $72.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$4K
AbbVie$3K
Carl Zeiss Meditec USA, Inc.$2K
Rxsight Inc$1K
Tarsus Pharmaceuticals, Inc.$746
Bausch & Lomb Americas Inc.$378
plus $2K from 15 others

What the payments were for

Consulting fees$1,40011%
Food & beverage$10,99389%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	52	$3,543
AbbVie(2 entities)	22	$2,688
Carl Zeiss Meditec USA, Inc.	21	$1,569
Rxsight Inc	19	$1,215
Tarsus Pharmaceuticals, Inc.	12	$746
Bausch & Lomb Americas Inc.	4	$378
Glaukos Corporation	6	$365
Rayner Intraocular Lenses Limited	2	$300
Lensar, Inc.	3	$263
Aerie Pharmaceuticals, Inc.	3	$240
Johnson & Johnson Surgical Vision, Inc.	4	$234
Sight Sciences, Inc.	6	$167
Dompe US, Inc.	2	$147
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$105
Carl Zeiss Meditec, Inc.	2	$95
Coopervision Inc.	2	$88
Ivantis, Inc	1	$70
NEW World Medical,inc.	1	$60
Biotissue Holdings Inc.	3	$51
Harrow Eye, LLC	2	$40
Lombart Brothers, Inc.	1	$27

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,393 in reported general payments places this provider in the 85th percentile of 1,355 ophthalmology providers in Texas.

See all ophthalmology providers in Texas →

Medicare billing

Part B allowed, 2024

$60,238

Medicare patients

Services billed

443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	34	$1,652
MoxifloxacinMoxifloxacin Hcl	31	$1,050
Timolol Maleate	11	$94
Latanoprost	25	$82

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Houston

John MichelettiHouston$916K
Christina WengHouston$676K
Peter ChangHouston$656K
Zaina Al-MohtasebHouston$636K
Stephen SladeHouston$530K
David BrownHouston$514K
Shaheen KavoussiHouston$480K
Elvia CansecoHouston$322K
Bac NguyenHouston$319K
Douglas KochHouston$308K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →